ArticleBMC medical genomics2023

Pan-cancer analysis of the prognostic and immunological role of SNX29: a potential target for survival and immunotherapy.

Chengfei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.